29
IRUS TotalDownloads
Network mapping of molecular biomarkers influencing radiation response in rectal cancer
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 1.35 MB | Adobe PDF | View/Open |
Title: | Network mapping of molecular biomarkers influencing radiation response in rectal cancer |
Authors: | Poynter, L Mirnezami, R Galea, D Veselkov, K Nicholson, J Takats, Z Darzi, A Kinross, J Mirnezami, A |
Item Type: | Journal Article |
Abstract: | Introduction Pre-operative radiotherapy (RT) has an important role in the management of locally advanced rectal cancer (RC). Tumour regression following RT shows marked variability and robust molecular methods are needed with which to predict likely response. The aim of this study was to review the current published literature and employ Gene Ontology (GO) analysis to define key molecular biomarkers governing radiation response in RC. Methods A systematic review of electronic bibliographic databases (MEDLINE, Embase) was performed for original articles published between 2000 and 2015. Biomarkers were then classified according to biological function and incorporated into a hierarchical GO tree. Both significant and non-significant results were included in the analysis. Significance was binarized based on uni- and multivariate statistics. Significance scores were calculated for each biological domain (or node), and a direct acyclic graph was generated for intuitive mapping of biological pathways and markers involved in rectal cancer radiation response. Results 72 individual biomarkers, across 74 studies, were identified through review. On highest order classification, molecular biomarkers falling within the domains of response to stress, cellular metabolism and pathways inhibiting apoptosis were found to be the most influential in predicting radiosensitivity. Conclusions Homogenising biomarker data from original articles using controlled GO terminology demonstrates that cellular mechanisms of response to radiotherapy in RC - in particular the metabolic response to radiotherapy - may hold promise in developing radiotherapeutic biomarkers with which to predict, and in the future modulate, radiation response. |
Issue Date: | 1-Jun-2019 |
Date of Acceptance: | 23-Jan-2019 |
URI: | http://hdl.handle.net/10044/1/67243 |
DOI: | 10.1016/j.clcc.2019.01.004 |
ISSN: | 1533-0028 |
Publisher: | Elsevier |
Start Page: | e210 |
End Page: | e222 |
Journal / Book Title: | Clinical Colorectal Cancer |
Volume: | 18 |
Issue: | 2 |
Copyright Statement: | © 2019 The Authors. Published by Elsevier Inc. Accepted manuscript available open access under a CC-BY-NC-ND Attribution 4.0 Licence 9https://creativecommons.org/licenses/by-nc-nd/4.0/) |
Sponsor/Funder: | Bowel Disease Research Foundation Imperial College Healthcare NHS Trust- BRC Funding National Institute of Health Research Commission of the European Communities Imperial College Healthcare NHS Trust- BRC Funding Imperial College Healthcare NHS Trust- BRC Funding Commission of the European Communities Cancer Research UK Micromass UK Ltd |
Funder's Grant Number: | RDA27 305940 RDB04 79560 RD207 617896 25038 WSSB_P72092 |
Keywords: | Science & Technology Life Sciences & Biomedicine Oncology Neoadjuvant therapy Radiation tolerance Radiotherapy Rectal neoplasms INDEPENDENT NEGATIVE PROGNOSTICATOR NEOADJUVANT CHEMORADIOTHERAPY TUMOR-REGRESSION PREOPERATIVE CHEMORADIOTHERAPY THYMIDYLATE-SYNTHASE PREDICTIVE MARKER DIHYDROPYRIMIDINE-DEHYDROGENASE CONCURRENT CHEMORADIOTHERAPY CYCLOOXYGENASE-2 EXPRESSION HISTOPATHOLOGICAL RESPONSE Neoadjuvant therapy Radiation tolerance Radiotherapy Rectal neoplasms 1112 Oncology and Carcinogenesis Oncology & Carcinogenesis |
Publication Status: | Published |
Online Publication Date: | 2019-02-10 |
Appears in Collections: | Department of Surgery and Cancer Institute of Global Health Innovation |